Selegiline Hydrochloride
- Product NDC
- 62135-694
- 11-digit product format
- 621350694
- Labeler code
- 62135
- Product ID
- 62135-694_17f2fc17-a150-214b-e063-6294a90ab548
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- Selegiline Hydrochloride
- Dosage form
- TABLET
- Route
- ORAL
- Labeler
- Chartwell RX, LLC
- Application
- ANDA074565
- Marketing category
- ANDA
- Marketing start
- 1996-08-02
- Substance
- SELEGILINE HYDROCHLORIDE
- Active strength
- 5 mg/1
- Pharmacologic classes
- Monoamine Oxidase Inhibitor [EPC], Monoamine Oxidase Inhibitors [MoA], Monoamine Oxidase Type B Inhibitor [EPC], Monoamine Oxidase-B Inhibitors [MoA]
- NDC exclude flag
- No
- Listing certified through
- 2026-12-31
- Current FDA listing
- Yes
Additional Listing Data#
- Finished product
- Yes
- Brand name base
- Selegiline Hydrochloride
- Listing expiration
- 2026-12-31
Active Ingredients#
Ingredient, Strength table| Ingredient | Strength |
|---|
| SELEGILINE HYDROCHLORIDE | 5 mg/1 |
Harmonized Identifiers#
Field, Values table| Field | Values |
|---|
| Unii | 6W731X367Q |
| Rxcui | 859193 |
DailyMed Product Concepts#
DailyMed Package Descriptions#
Package NDC, Product, Description table| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|
| 62135-694-60 | Selegiline Hydrochloride | 60 in 1 BOTTLE | TABLET | 60 | | 1 |
DailyMed Dashboard NDC Coverage#
NDC, Dashboard title, SPL version table| NDC | Dashboard title | SPL version | Validation | Dashboard ZIP |
|---|
| 62135-694 | SELEGILINE HYDROCHLORIDE TABLET [CHARTWELL RX, LLC] | 1 | Current NDC, 1 package rows | 20240509_189ac32d-28b4-47c5-9de6-318e502eff3b.zip |
DailyMed RxNorm Mappings#
Packages#
Package NDC, 11-digit format, Description table| Package NDC | 11-digit format | Description | Units | Marketing start | Sample | Exclude flag | Status |
|---|
| 62135-694-60 | 62135069460 | 60 TABLET in 1 BOTTLE (62135-694-60) | 60 tablet | 2024-05-06 | No | No | Current |